PerkinElmer
Top Five Articles on 360Dx Last Week: PerkinElmer Acquisition; November FDA Clearances; More
Last week, readers were most interested in a story about PerkinElmer acquiring life sciences firm Covaris.
PerkinElmer Acquires Life Sciences Firm Covaris
Less than a year post-divestment from Revvity's life sciences and diagnostics business, PerkinElmer has inked a deal to expand its own life sciences portfolio.
Revvity Q2 Revenues Down on COVID Testing Declines; Organic Dx Revenues Rise
The firm reported 8 percent organic growth in diagnostics, excluding COVID-19, but it also saw lower spending on instruments, contracts, and technology deals.
The firm reported Thursday its Q1 revenues declined 30 percent as COVID-19 revenues dwindled but non-COVID organic revenues grew 6 percent.
In Brief This Week: PerkinElmer, CDC, Opko, DermTech, OpGen, More
News items for the week of May 1, 2023.